Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

Immunology: An Alternative Route to Inflammation

March 31, 2016 8:42 am | by Ludwig-Maximilians Universitat Munchen | News | Comments

Scientists have defined a previously unknown pathway that triggers inflammation. Read more...


Japan Approves Marketing Authorization for GSK's Nucala

March 31, 2016 8:37 am | News | Comments

Approval in Japan comes just four months after the approval of Nucala in the US. Read more...


New Drug Shows Promise Against Muscle-Wasting Disease

March 31, 2016 8:31 am | by University College London | News | Comments

IBM is the most common muscle disease in people over 45. Read more...


Nonpathogenic Viruses Transferred During Fecal Transplants

March 30, 2016 11:21 am | by American Society for Microbiology | News | Comments

Immunities of viruses can be transferred during fecal transplants, according to a study published this week in mBio, an online open-access journal of the American Society for Microbiology. Read more..


New Tool Mines Whole-Exome Sequencing Data to Match Cancer with Best Drug

March 30, 2016 11:11 am | by University of Colorado | News | Comments

A University of Colorado Cancer study published today in the Journal of the American Medical Informatics Association (JAMIA) describes a new tool that interprets the raw data of whole exome tumor sequencing and then matches the cancer's unique genetics to FDA-approved targeted treatments. Read more..

Gov't Panel Backs Drug for Delusions in Parkinson's Patients

March 30, 2016 10:56 am | by Matthew Perrone, AP Health Writer | News | Comments

Federal health experts have endorsed an experimental drug intended to treat psychotic delusions and behaviors that often afflict patients with Parkinson's disease, the debilitating movement disorder. Read more...


Nanoparticles Deliver Anticancer Cluster Bombs

March 30, 2016 10:46 am | by Emory Health Sciences | News | Comments

Scientists have devised a triple-stage "cluster bomb" system for delivering the chemotherapy drug cisplatin, via tiny nanoparticles designed to break up when they reach a tumor. Read more..


Sanofi Pasteur: Strategy for 2nd-Gen Influenza Vaccine

March 30, 2016 10:38 am | News | Comments

Sanofi Pasteur, the vaccines division of Sanofi, announces published data on a vaccine strategy that elicited a broadly-reactive response against seasonal and pandemic H1N1 influenza viruses in mice. Read more..


Blood Test for Concussions? Researchers Report Some Progress

March 30, 2016 10:17 am | News | Comments

New research bolsters evidence that a simple blood test may someday be used to detect concussions. Read more..


WHO: Ebola No Longer World Health Emergency

March 30, 2016 8:33 am | by Krista Larson, Associated Press | News | Comments

The announcement puts an end to the international emergency declaration that has been controversial. Read more...


Discovery Offers Key for Combating Muscular Dystrophy

March 30, 2016 8:32 am | by Kobe University | News | Comments

Muscular dystrophy is an incurable genetic condition marked by progressive weakening of the muscles. Read more...


WHO: More Oversight Needed after China's Vaccine Scandal

March 30, 2016 8:31 am | by Louise Watt, Associated Press | News | Comments

The scandal reinforces long-standing public concerns over the safety of China's food and medicine supply. Read more...


UGA, Sanofi Develop New Flu Vaccine

March 30, 2016 8:31 am | by University of Georgia | News | Comments

The H1N1 influenza virus caused a worldwide pandemic in 2009. Read more...


U.S. Firms Target Investment in Israeli Cannabis R&D

March 30, 2016 8:30 am | by Maayan Lubell, Reuters | News | Comments

Israel is starting to attract American companies looking to bring medical marijuana know-how to a booming market back home. Read more...


Meet Sanofi's Newest R&D Chief

March 30, 2016 8:23 am | by Ryan Bushey, Digital Editor | News | Comments

A top scientist at AstraZeneca has left the company to join the French drug maker. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.